Steen Lisby's most recent trade in Y-Mabs Therapeutics Inc was a trade of 35,700 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Lisby Steen | SVP & CHIEF SCIENTIFIC OFFICER | 18 Jan 2024 | 35,700 | 35,700 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Lisby Steen | SVP & CHIEF SCIENTIFIC OFFICER | 18 Jan 2024 | 17,800 | 35,600 (0%) | 0% | 0 | Common Stock | ||
| Y-Mabs Therapeutics Inc | Steen Lisby | SVP & CHIEF SCIENTIFIC OFFICER | 26 Jan 2023 | 32,000 | 32,000 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Steen Lisby | SVP & CHIEF SCIENTIFIC OFFICER | 17 Jan 2023 | 35,700 | 35,700 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Steen Lisby | SVP & CHIEF SCIENTIFIC OFFICER | 17 Jan 2023 | 17,800 | 17,800 (0%) | 0% | 0 | Common stock | ||
| Y-Mabs Therapeutics Inc | Steen Lisby | SVP & CSO | 26 Apr 2022 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Steen Lisby | SVP & CSO | 14 Dec 2021 | 32,000 | 32,000 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Steen Lisby | SVP & CSO | 15 Dec 2020 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) |